Responsiveness and clinically important differences for the WOMAC and SF-36 after hip joint replacement

Ware, 1992, The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection, Med Care, 30, 473, 10.1097/00005650-199206000-00002 Hawker, 1995, Comparison of a generic (SF-36) and a disease specific (WOMAC) (Western Ontario and McMaster Universities Osteoarthritis Index) instrument in the measurement of outcomes after knee replacement surgery, J Rheumatol, 22, 1193 Nilsdotter, 2001, Comparative responsiveness of measures of pain and function after total hip replacement, Arthritis Rheum, 45, 258, 10.1002/1529-0131(200106)45:3<258::AID-ART258>3.0.CO;2-L Beaton, 2003, Measures of health-related quality of life and physical function, Clin Orthop, 413, 90, 10.1097/01.blo.0000079772.06654.c8 Bellamy, 1988, Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee, J Rheumatol, 15, 1833 March, 2002, Cost of joint replacement surgery for osteoarthritis: the patients' perspective, J Rheumatol, 29, 1006 Jones, 2001, The effect of age on pain, function, and quality of life after total hip and knee arthroplasty, Arch Intern Med, 161, 454, 10.1001/archinte.161.3.454 Jones, 2000, Health related quality of life outcomes after total hip and knee arthroplasties in a community based population, J Rheumatol, 27, 1745 Dawson, 1996, Comparison of measures to assess outcomes in total hip replacement surgery, Qual Health Care, 5, 81, 10.1136/qshc.5.2.81 Nilsdotter, 2003, Hip disability and osteoarthritis outcome score (HOOS)—validity and responsiveness in total hip replacement, BMC Musculoskelet Disord, 4, 10, 10.1186/1471-2474-4-10 Fortin, 2002, Timing of total joint replacement affects clinical outcomes among patients with osteoarthritis of the hip or knee, Arthritis Rheum, 46, 3327, 10.1002/art.10631 Angst, 2001, Responsiveness of the WOMAC osteoarthritis index as compared with the SF-36 in patients with osteoarthritis of the legs undergoing a comprehensive rehabilitation intervention, Ann Rheum Dis, 60, 834 Davies, 1999, Comparison of the responsiveness and relative effect size of the western Ontario and McMaster Universities Osteoarthritis Index and the short-form Medical Outcomes Study Survey in a randomized, clinical trial of osteoarthritis patients, Arthritis Care Res, 12, 172, 10.1002/1529-0131(199906)12:3<172::AID-ART4>3.0.CO;2-Y Schmitt, 2004, Reliable change and minimum important difference (MID) proportions facilitated group responsiveness comparisons using individual threshold criteria, J Clin Epidemiol, 57, 1008, 10.1016/j.jclinepi.2004.02.007 Guyatt, 2002, Methods to explain the clinical significance of health status measures, Mayo Clin Proc, 77, 371, 10.4065/77.4.371 Hays, 2000, The concept of clinically meaningful difference in health-related quality-of-life research. How meaningful is it?, Pharmacoeconomics, 18, 419, 10.2165/00019053-200018050-00001 Strand, 2004, Outcome measures in osteoarthritis: randomized controlled trials, Curr Rheumatol Rep, 6, 20, 10.1007/s11926-004-0080-6 Ehrich, 2000, Minimal perceptible clinical improvement with the Western Ontario and McMaster Universities osteoarthritis index questionnaire and global assessments in patients with osteoarthritis, J Rheumatol, 27, 2635 Angst, 2001, Arthritis Rheum, 45, 384, 10.1002/1529-0131(200108)45:4<384::AID-ART352>3.0.CO;2-0 Theiler, 1999, Superior responsiveness of the pain and function sections of the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) as compared to the Lequesne-Algofunctional Index in patients with osteoarthritis of the lower extremities, Osteoarthritis Cartilage, 7, 515, 10.1053/joca.1999.0262 Wright, 1997, A comparison of different indices of responsiveness, J Clin Epidemiol, 50, 239, 10.1016/S0895-4356(96)00373-3 Charlson, 1987, A new method of classifying prognostic comorbidity in longitudinal studies: development and validation, J Chronic Dis, 40, 373, 10.1016/0021-9681(87)90171-8 Alonso, 1998, Population reference values of the Spanish version of the Health Questionnaire SF-36, Med Clin (Barc), 111, 410 Alonso, 1995, The Spanish version of the SF-36 Health Survey (the SF-36 health questionnaire): an instrument for measuring clinical results, Med Clin (Barc), 104, 771 Brazier, 2002, The estimation of a preference-based measure of health from the SF-36, J Health Econ, 21, 271, 10.1016/S0167-6296(01)00130-8 Escobar, 2002, Validation of the Spanish version of the WOMAC questionnaire for patients with hip or knee osteoarthritis. Western Ontario and McMaster Universities Osteoarthritis Index, Clin Rheumatol, 21, 466, 10.1007/s100670200117 Nunnally, 1994 Jaeschke, 1989, Measurement of health status. Ascertaining the minimal clinically important difference, Control Clin Trials, 10, 407, 10.1016/0197-2456(89)90005-6 Wyrwich, 1999, Further evidence supporting an SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life, J Clin Epidemiol, 52, 861, 10.1016/S0895-4356(99)00071-2 Cohen, 1992, A power primer, Psychol Bull, 112, 155, 10.1037/0033-2909.112.1.155 Norman, 1997, Methodological problems in the retrospective computation of responsiveness to change: the lesson of Cronbach, J Clin Epidemiol, 50, 869, 10.1016/S0895-4356(97)00097-8 Wyrwich, 2004, Minimal important difference thresholds and the standard error of measurement: is there a connection?, J Biopharm Stat, 14, 97, 10.1081/BIP-120028508 Tubach, 2005, Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement, Ann Rheum Dis, 64, 29, 10.1136/ard.2004.022905 Kirwan, 2001, Minimum clinically important difference: the crock of gold at the end of the rainbow?, J Rheumatol, 28, 439